Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
Clinical trial NCT07422779 · RECRUITING
Trial details
- NCT number
- NCT07422779
- Sponsor
- Institute of Oncology Ljubljana
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2027-03-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.